A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer. (Q41063959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

title

A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

Philippe L. Bedard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

Tracy Stockley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

Suzanne Kamel-Reid

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

6

Lillian Siu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Kenneth J Craddock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

Mariam Thomas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

Aaron R Hansen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

Tong Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

16 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

128-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25880439 AND SRC:MED&resulttype=core&format=json

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

5 March 2020

cites work

1 reference

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes

21 January 2018

1 reference

Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting

21 January 2018

1 reference

Incidental findings in clinical genomics: a clarification

21 January 2018

1 reference

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

21 January 2018

1 reference

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular

21 January 2018

1 reference

Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

21 January 2018

1 reference

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

21 January 2018

1 reference

BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel.

21 January 2018

1 reference

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

21 January 2018

1 reference

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma.

21 January 2018

1 reference

Clinical Implementation of Comprehensive Strategies to Characterize Cancer Genomes: Opportunities and Challenges

21 January 2018

1 reference

Assuring the quality of next-generation sequencing in clinical laboratory practice

21 January 2018

1 reference

ACMG clinical laboratory standards for next-generation sequencing

21 January 2018

1 reference

Evolution and functional impact of rare coding variation from deep sequencing of human exomes

21 January 2018

1 reference

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

A guide to GRADE guidelines for the readers of JTH.

21 January 2018

1 reference

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology

21 January 2018

1 reference

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

GRADE guidelines: 2. Framing the question and deciding on important outcomes.

21 January 2018

1 reference

GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

21 January 2018

1 reference

GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes

21 January 2018

1 reference

The EGAPP initiative: lessons learned

21 January 2018

1 reference

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 January 2018

1 reference

KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

21 January 2018

1 reference

EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

21 January 2018

1 reference

PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials

21 January 2018

1 reference

Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors

21 January 2018

1 reference

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen

21 January 2018

1 reference

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

21 January 2018

1 reference

Systematic identification of genomic markers of drug sensitivity in cancer cells

21 January 2018

1 reference

Comparison and validation of genomic predictors for anticancer drug sensitivity

21 January 2018

1 reference

Drug development: Raise standards for preclinical cancer research

21 January 2018

1 reference

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25880439

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

GRADE guidelines-an introduction to the 10th-13th articles in the series

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25880439